| pubmed-article:16490816 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16490816 | lifeskim:mentions | umls-concept:C0010055 | lld:lifeskim |
| pubmed-article:16490816 | lifeskim:mentions | umls-concept:C0232804 | lld:lifeskim |
| pubmed-article:16490816 | lifeskim:mentions | umls-concept:C0026565 | lld:lifeskim |
| pubmed-article:16490816 | lifeskim:mentions | umls-concept:C1522577 | lld:lifeskim |
| pubmed-article:16490816 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:16490816 | pubmed:issue | 8 | lld:pubmed |
| pubmed-article:16490816 | pubmed:dateCreated | 2006-2-28 | lld:pubmed |
| pubmed-article:16490816 | pubmed:abstractText | Severe renal dysfunction is associated with a worse outcome after coronary artery bypass graft surgery (CABG). Less is known about the effects of milder degrees of renal impairment, and previous studies have relied on levels of serum creatinine, an insensitive indicator of renal function. Recent studies have suggested that estimated glomerular filtration rate (eGFR) is a more discriminatory measure. However, data on the utility of eGFR in predicting outcome from CABG are limited. | lld:pubmed |
| pubmed-article:16490816 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16490816 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16490816 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16490816 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:16490816 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16490816 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:16490816 | pubmed:issn | 1524-4539 | lld:pubmed |
| pubmed-article:16490816 | pubmed:author | pubmed-author:HillisGraham... | lld:pubmed |
| pubmed-article:16490816 | pubmed:author | pubmed-author:JeffreyRobert... | lld:pubmed |
| pubmed-article:16490816 | pubmed:author | pubmed-author:PrescottGordo... | lld:pubmed |
| pubmed-article:16490816 | pubmed:author | pubmed-author:MillarColin... | lld:pubmed |
| pubmed-article:16490816 | pubmed:author | pubmed-author:CuthbertsonBr... | lld:pubmed |
| pubmed-article:16490816 | pubmed:author | pubmed-author:BuchanKeith... | lld:pubmed |
| pubmed-article:16490816 | pubmed:author | pubmed-author:CroalBernie... | lld:pubmed |
| pubmed-article:16490816 | pubmed:author | pubmed-author:El-ShafeiHuss... | lld:pubmed |
| pubmed-article:16490816 | pubmed:author | pubmed-author:GibsonGeorgeG | lld:pubmed |
| pubmed-article:16490816 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:16490816 | pubmed:day | 28 | lld:pubmed |
| pubmed-article:16490816 | pubmed:volume | 113 | lld:pubmed |
| pubmed-article:16490816 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16490816 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16490816 | pubmed:pagination | 1056-62 | lld:pubmed |
| pubmed-article:16490816 | pubmed:meshHeading | pubmed-meshheading:16490816... | lld:pubmed |
| pubmed-article:16490816 | pubmed:meshHeading | pubmed-meshheading:16490816... | lld:pubmed |
| pubmed-article:16490816 | pubmed:meshHeading | pubmed-meshheading:16490816... | lld:pubmed |
| pubmed-article:16490816 | pubmed:meshHeading | pubmed-meshheading:16490816... | lld:pubmed |
| pubmed-article:16490816 | pubmed:meshHeading | pubmed-meshheading:16490816... | lld:pubmed |
| pubmed-article:16490816 | pubmed:meshHeading | pubmed-meshheading:16490816... | lld:pubmed |
| pubmed-article:16490816 | pubmed:meshHeading | pubmed-meshheading:16490816... | lld:pubmed |
| pubmed-article:16490816 | pubmed:meshHeading | pubmed-meshheading:16490816... | lld:pubmed |
| pubmed-article:16490816 | pubmed:meshHeading | pubmed-meshheading:16490816... | lld:pubmed |
| pubmed-article:16490816 | pubmed:meshHeading | pubmed-meshheading:16490816... | lld:pubmed |
| pubmed-article:16490816 | pubmed:meshHeading | pubmed-meshheading:16490816... | lld:pubmed |
| pubmed-article:16490816 | pubmed:meshHeading | pubmed-meshheading:16490816... | lld:pubmed |
| pubmed-article:16490816 | pubmed:meshHeading | pubmed-meshheading:16490816... | lld:pubmed |
| pubmed-article:16490816 | pubmed:meshHeading | pubmed-meshheading:16490816... | lld:pubmed |
| pubmed-article:16490816 | pubmed:year | 2006 | lld:pubmed |
| pubmed-article:16490816 | pubmed:articleTitle | Renal function and outcome from coronary artery bypass grafting: impact on mortality after a 2.3-year follow-up. | lld:pubmed |
| pubmed-article:16490816 | pubmed:affiliation | Department of Cardiology, University of Aberdeen, Aberdeen Royal Infirmary, UK. g.hillis@abdn.ac.uk | lld:pubmed |
| pubmed-article:16490816 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16490816 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16490816 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16490816 | lld:pubmed |
